FHL1 inhibits both anchorage-dependent and -independent breast cancer cell growth, which could be mediated by physical and functional interactions with estrogen receptors (ER) and modulation of transcriptional activities of ERα and ERβ. Here, FHL1 is linked to breast carcinoma.